New Test Rapidly Detects Trace Pesticides in Foods
By LabMedica International staff writers Posted on 20 Nov 2009 |
A "dipstick” test to identify small amounts of pesticides in foods and beverages produces results in minutes rather than hours, by means of a color changing paper-strip.
Researchers at McMaster University (Hamilton, ON, USA) developed the reagent-less, bioactive paper-based solid-phase biosensor, which can be used for the detection of acetylcholinesterase (AChE) inhibitors, which include organophosphate pesticides. The assay strip is composed of a paper support strip, onto which AChE and a chromogenic substrate, indophenyl acetate (IPA) are entrapped using biocompatible sol-gel derived silica inks in two different zones (the sensing and substrate zones). The assay protocol involves first introducing the sample to the sensing zone via lateral flow of a pesticide-containing solution. Following an incubation period, the opposite end of the paper support is placed into distilled deionized water (ddH2O) to allow lateral flow in the opposite direction, thus moving the paper-bound IPA to the sensing area and initiating enzyme catalyzed hydrolysis of the substrate, which causes a yellow-to-blue color change.
The modified sensor is able to detect pesticides without the use of any external reagents, with excellent detection limits and rapid response times of approximately five minutes. In field tests, the sensor strip showed negligible matrix effects in the detection of pesticides in spiked milk and apple juice samples. Bioactive paper-based assays on pesticide residues collected from food samples showed good agreement with a conventional mass spectrometric assay method. The study describing the biosensor was published in the November 1, 2009, issue of Analytical Chemistry.
"The bioactive paper assay should, therefore, be suitable for rapid screening of trace levels of organophosphate and carbamate pesticides in environmental and food samples,” concluded lead author John Brennan, Ph.D., and colleagues of the department of chemistry and chemical biology.
Conventional tests for detecting pesticides tend to use complex mass spectrographic equipment, and in some cases can take several hours to produce results. A growing need for cheaper, more convenient, and more eco-friendly tests for pesticides is being seen, particularly in the food industry and in developing countries or remote areas that may lack access to expensive testing equipment and electricity.
Related Links:
McMaster University
Researchers at McMaster University (Hamilton, ON, USA) developed the reagent-less, bioactive paper-based solid-phase biosensor, which can be used for the detection of acetylcholinesterase (AChE) inhibitors, which include organophosphate pesticides. The assay strip is composed of a paper support strip, onto which AChE and a chromogenic substrate, indophenyl acetate (IPA) are entrapped using biocompatible sol-gel derived silica inks in two different zones (the sensing and substrate zones). The assay protocol involves first introducing the sample to the sensing zone via lateral flow of a pesticide-containing solution. Following an incubation period, the opposite end of the paper support is placed into distilled deionized water (ddH2O) to allow lateral flow in the opposite direction, thus moving the paper-bound IPA to the sensing area and initiating enzyme catalyzed hydrolysis of the substrate, which causes a yellow-to-blue color change.
The modified sensor is able to detect pesticides without the use of any external reagents, with excellent detection limits and rapid response times of approximately five minutes. In field tests, the sensor strip showed negligible matrix effects in the detection of pesticides in spiked milk and apple juice samples. Bioactive paper-based assays on pesticide residues collected from food samples showed good agreement with a conventional mass spectrometric assay method. The study describing the biosensor was published in the November 1, 2009, issue of Analytical Chemistry.
"The bioactive paper assay should, therefore, be suitable for rapid screening of trace levels of organophosphate and carbamate pesticides in environmental and food samples,” concluded lead author John Brennan, Ph.D., and colleagues of the department of chemistry and chemical biology.
Conventional tests for detecting pesticides tend to use complex mass spectrographic equipment, and in some cases can take several hours to produce results. A growing need for cheaper, more convenient, and more eco-friendly tests for pesticides is being seen, particularly in the food industry and in developing countries or remote areas that may lack access to expensive testing equipment and electricity.
Related Links:
McMaster University
Latest Clinical Chem. News
- New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
- New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
- Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
- Simple Urine Test Could Detect Multiple Cancers at Early Stage
- Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules
- First-Of-Its-Kind Quantitative Method Assesses Opioid Exposure in Newborns
- Paper-Based Devices Outperform Existing Methods in Diagnosing Asymptomatic Malaria
- Simple Skin Test Could Revolutionize Diagnosis of Pediatric Eosinophilic Esophagitis
- Portable Diagnostic Tool Uses Bioluminescence to Detect Viruses at POC
- AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress
- AI-Powered Blood Test Accurately Detects Ovarian Cancer
- Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors
- Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
- First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
- Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
- ‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Channels
Clinical Chemistry
view channel
New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read moreMolecular Diagnostics
view channel
Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age
As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more
RNA Screening Test Could Detect Colon Polyps Before They Become Cancerous
Colorectal cancer has become a growing health crisis, especially as it increasingly affects younger adults in their 20s, 30s, and 40s, while screening rates remain low. Colorectal cancer is now the leading... Read more
New RT-LAMP Assay Offers Affordable and Reliable Pathogen Detection for Resource-Limited Settings
The high cost and logistical complexities associated with rapid, point-of-care tests have long hampered widespread access to molecular diagnostics, especially in low- and middle-income countries.... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer
Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more
Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes
Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read moreMicrobiology
view channel
Viral Load Tests Can Help Predict Mpox Severity
Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more
Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read morePathology
view channel
Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels
Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more
New AI-Based Method Effectively Identifies Disease Phenotypes Using Light-Based Imaging
Precision medicine, where treatment strategies are tailored to a patient's unique disease characteristics, holds great promise for cancer therapy. However, identifying disease phenotypes, which are critical... Read more
AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care
Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read moreTechnology
view channel
Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation
Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Ultra-Sensitive Biosensor Based on Light and AI Enables Early Cancer Diagnosis
Cancer diagnosis is often delayed due to the difficulty in detecting early-stage cancer markers. In particular, the concentration of methylated DNA in the bloodstream during the early stages of cancer... Read moreIndustry
view channel
BD Biosciences & Diagnostic Solutions to Merge with Waters
BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and Waters Corporation (Milford, MA, USA) have entered into a definitive agreement to combine BD's Biosciences & Diagnostic Solutions... Read more